Novorapid vs. Actrapid: Key Differences for Diabetes Management

Both Novorapid (insulin aspart) and Actrapid (human insulin) are short-acting insulins for mealtime blood sugar control, but differ in pharmacokinetics:

1. Speed of Action

  • Novorapid: Onset ~10–20 minutes; peaks quickly—ideal for mimicking natural post-meal insulin release.
  • Actrapid: Onset ~30–60 minutes; slightly slower peak.

2. Duration of Action

  • Novorapid: 3–5 hours—shorter coverage, allows frequent dose adjustments.
  • Actrapid: 6–8 hours—longer coverage, suited for less frequent dosing or stable patterns.

3. Side Effect Profile

  • Novorapid: Slightly higher hypoglycemia risk due to rapid onset/short duration.
  • Actrapid: Rare allergic reactions (rash, itching) reported more often.

Choice depends on individual glucose patterns, meal routines, lifestyle, and physician assessment. Always consult your healthcare provider.

Diabetes - Related Articles